Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

ORIGINAL ARTICLE

Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer

Online download statistics by month:

Online download statistics by month: March 2019 to March 2023

	Abstract	Full	Pdf
Mar 2019	6	0	0
Apr 2019	14	0	0
May 2019	20	0	0
Jun 2019	16	0	1
Jul 2019	18	0	0
Aug 2019	15	0	0
Sep 2019	16	0	0
Oct 2019	22	0	0
Nov 2019	10	0	0
Dec 2019	6	0	0
Jan 2020	26	0	0
Feb 2020	22	0	0
Mar 2020	2	0	0
Apr 2020	10	0	0
May 2020	18	0	0
Jun 2020	22	0	0
Jul 2020	10	0	0
Aug 2020	8	0	0
Sep 2020	7	0	0
Oct 2020	11	0	1
Nov 2020	10	0	0
Dec 2020	12	0	0
Jan 2021	10	0	0
Feb 2021	2	0	0
Mar 2021	13	0	0
Apr 2021	6	0	0
May 2021	3	0	0
Oct 2021	15	0	1
Nov 2021	2	0	0
Dec 2021	22	0	1
Jan 2022	20	0	1
Feb 2022	8	0	0
Mar 2022	12	0	1
Apr 2022	12	0	1
May 2022	36	0	1
Jun 2022	44	0	3
Jul 2022	24	0	3
Aug 2022	64	0	1
Sep 2022	50	0	2
Oct 2022	44	0	1
Nov 2022	30	0	1
Dec 2022	20	0	2
Jan 2023	20	0	1
Feb 2023	52	0	2
Mar 2023	10	0	0
Total	820	0	24